Bottom-up Approach and Top-down Approach The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process
The FDA recently approved versions of GLP-1 medication - including Wegovy (semaglutide), Saxenda (liraglutide), and Zepbound (tirzepatide) - for chronic weight management
In consideration of the multiple metabolic and cardiovascular effects seen in subjects treated with GLP-1RAs and SGLT-2is (e.g., reduction of hyperglycemia, weight loss, free/fat mass and bone remodeling, anti-atherosclerosis, natriuresis), it is reasonable to speculate that GH and IGF-1 may play a about a relevant role in this context
PubMed Coskun T, et al
How Do You Know When Semaglutide GLP-1 Is Working
2023 is the accessible mechanistic comparison of tirzepatide and semaglutide and is worth reading alongside Willard for the signaling-bias piece